glp 1 drugs and hashimoto's GLP-1 Agonists: A Comprehensive Overview Upcoming wave of hormone-based therapies
Description
Strategies to correct the incretin defects in patients with type 2 diabetes include replacement of GLP-1 with a long-acting analog that resists degradation and development of drugs that inhibit the enzyme DPP-4, which breaks down GLP-1
Most people find the nausea manageable after the first month
Curr Obes Rep 12 , 6174 (2023)
Despite the encouraging findings, both research teams emphasize that the evidence remains preliminary
This novel theme is emerging as researchers investigate the drug's impact on weight reduction and its safety profile in diverse demographic groups
